Search Results - daniela+salvemini

6 Results

Sort By:

Selective A3 Adenosine Receptor Agonists for the Treatment of Chronic Neuropathic Pain and Other Conditions

This technology includes the creation and use of A3 adenosine receptor (A3AR)-selective agonists for treating chemotherapy-induced peripheral neuropathy, chronic neuropathic pain, rheumatoid arthritis, psoriasis, and other conditions. A3 receptors for adenosine are found in most cells and endogenous activation of the A3 receptors can result in apoptosis,...

Published: 8/12/2024 | Inventor(s): Daniela Salvemini, Dilip Tosh, Kenneth Jacobson

Keywords(s):

Category(s): Application, Application > Therapeutics, Collaboration Sought > Collaboration, Collaboration Sought > Licensing, TherapeuticArea > Cardiology, TherapeuticArea > Dermatology, TherapeuticArea > Immunology, TherapeuticArea > Oncology

Treating and Preventing Neuropathic Pain Using Novel Non-Narcotic Analgesics

Published: 6/15/2022 | Inventor(s): Daniela Salvemini, Kenneth Jacobson

Keywords(s):

Category(s): Therapeutics

Treating Neuropathic Pain with Greater Selectivity

Published: 6/14/2021 | Inventor(s): Daniela Salvemini, Christopher Arnatt

Keywords(s):

Category(s): Therapeutics

Treating Chronic Neuropathic Pain